COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

202306_BB_USP Chapter 795.png

Read what we’re doing to ensure PCCA Formulas for compounding nonsterile preparations — specifically beyond-use dates — comply with USP Chapter 795 revisions.

202302_USP_795-1768x9232 (1).jpg

Our four-part series continues with Part 2, USP 795 revisions and impacts on compounding pharmacies.

202301_Blog_Cleanroom2_1768x923 (1).jpg

A modular compounding cleanroom is a great way to meet evolving regulatory requirements and standards. Learn the basics of a modular cleanroom in the first in a series of articles on Modular Compounding Cleanrooms.

The_Top_5_Blog_Posts_of_2019.png

Thank you to all of our readers and subscribers for supporting the PCCA blog, your support is what makes it the best compounding pharmacy blog online! We’re grateful to be able to produce content that professionals in the pharmacy compounding industry find valuable. With that said, come check out the top five, most valuable PCCA Blog Posts of 2019 that you might have missed!

Upcoming_Changes_to_PCCA_Formulas_per_the_New_USP_795_797_and_800_Part_Two.png

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part two in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines. This particular section focuses on USP <797>.

Upcoming_Changes_to_PCCA_Formulas_per_the_New_USP_795_797_and_800_Part_One.png

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part one in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines.

Notable_Changes_in_the_New_USP_795.png

The only thing that stays the same is that everything changes. This is true even when it comes to nonsterile compounding and USP <795>. PCCA Clinical Compounding Pharmacist Matt Martin, PharmD, addresses notable changes of the new USP guidelines and provides some considerations regarding implementation.